体外診断用医薬品の世界市場2022年-2026年

◆英語タイトル:Global In-vitro Diagnostics Market 2022-2026

Technavioが発行した調査報告書(IRTNTR71317-22)◆商品コード:IRTNTR71317-22
◆発行会社(リサーチ会社):Technavio
◆発行日:2022年9月26日
◆ページ数:約120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Technavio社の調査レポートによると、世界の体外診断用医薬品市場規模は2022年から2026年まで年平均23.19%成長し、331.6億ドルに拡大する見通しです。本書では、体外診断用医薬品の世界市場を調査対象とし、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、技術別(イムノアッセイ、分子診断、臨床化学、血液、その他)分析、顧客状況、地域別状況(北米、ヨーロッパ、アジア、アメリカ、中国、日本、ドイツ、カナダ)分析、推進要因・課題・動向、企業状況、企業分析などを以下の項目で掲載しています。本書には、主要プレイヤーとしてAbbott Laboratories、Agilent Technologies Inc.、ARKRAY Inc.、Becton Dickinson and Co.、BGI Group、Bio Rad Laboratories Inc.、bioMerieux SA、Danaher Corp.、DiaSorin SpA、F. Hoffmann La Roche Ltd.、Grifols SA、Illumina Inc.などの企業情報が含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析

・世界の体外診断用医薬品市場規模:技術別
- イムノアッセイ用医薬品の市場規模2022-2026
- 分子診断用医薬品の市場規模2022-2026
- 臨床化学用医薬品の市場規模2022-2026
- 血液用医薬品の市場規模2022-2026
- その他技術の市場規模2022-2026

・顧客状況

・地域別状況
- 北米の体外診断用医薬品市場規模2022-2026
- ヨーロッパの体外診断用医薬品市場規模2022-2026
- アジアの体外診断用医薬品市場規模2022-2026
- アメリカの体外診断用医薬品市場規模2022-2026
- 中国の体外診断用医薬品市場規模2022-2026
- 日本の体外診断用医薬品市場規模2022-2026
- ドイツの体外診断用医薬品市場規模2022-2026
- カナダの体外診断用医薬品市場規模2022-2026

・推進要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

Global In-vitro Diagnostics Market 2022-2026

Technavio has been monitoring the in-vitro diagnostics market and it is poised to grow by $ 33.16 bn during 2022-2026、accelerating at a CAGR of 6.89% during the forecast period. Our report on the in-vitro diagnostics market provides a holistic analysis、market size and forecast、trends、growth drivers、and challenges、as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario、the latest trends and drivers、and the overall market environment. The market is driven by the increasing geriatric population、chronic、and infectious diseases、high demand for personalized medicine、and increasing investments in drug discovery.

The in-vitro diagnostics market analysis includes the technology segment and geographic landscape.
Technavio’s in-vitro diagnostics market is segmented as below:

By Technology
• Immunoassay
• Molecular diagnostics
• Clinical chemistry
• Hematology
• Others

By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the technological advances in in-vitro diagnostics as one of the prime reasons driving the in-vitro diagnostics market growth during the next few years. Also、the global adoption of advanced treatment solutions and innovations in the digital in-vitro diagnostics sector will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study、synthesis、and summation of data from multiple sources by an analysis of key parameters. Our report on the in-vitro diagnostics market covers the following areas:
• In-vitro diagnostics market sizing
• In-vitro diagnostics market forecast
• In-vitro diagnostics market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position、and in line with this、this report provides a detailed analysis of several leading in-vitro diagnostics market vendors that include Abbott Laboratories、Agilent Technologies Inc.、ARKRAY Inc.、Becton Dickinson、and Co.、BGI Group、Bio Rad Laboratories Inc.、bioMerieux SA、Danaher Corp.、DiaSorin SpA、F. Hoffmann La Roche Ltd.、Grifols SA、Illumina Inc.、Ortho Clinical Diagnostics plc、QIAGEN NV、Quest Diagnostics Inc.、Siemens AG、Sysmex Corp、and Thermo Fisher Scientific Inc. Also、the in-vitro diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study、synthesis、and summation of data from multiple sources by an analysis of key parameters such as profit、pricing、competition、and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive、reliable、and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Technology
o Exhibit 06: Executive Summary – Chart on Incremental Growth
o Exhibit 07: Executive Summary – Data Table on Incremental Growth
o Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ billion)
o Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ billion)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis – Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition – Five forces 2021 and 2026
• 5 Market Segmentation by Technology
o 5.1 Market segments
o Exhibit 24: Chart on Technology – Market share 2021-2026 (%)
o Exhibit 25: Data Table on Technology – Market share 2021-2026 (%)
o 5.2 Comparison by Technology
o Exhibit 26: Chart on Comparison by Technology
o Exhibit 27: Data Table on Comparison by Technology
o 5.3 Immunoassay – Market size and forecast 2021-2026
o Exhibit 28: Chart on Immunoassay – Market size and forecast 2021-2026 ($ billion)
o Exhibit 29: Data Table on Immunoassay – Market size and forecast 2021-2026 ($ billion)
o Exhibit 30: Chart on Immunoassay – Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Immunoassay – Year-over-year growth 2021-2026 (%)
o 5.4 Molecular diagnostics – Market size and forecast 2021-2026
o Exhibit 32: Chart on Molecular diagnostics – Market size and forecast 2021-2026 ($ billion)
o Exhibit 33: Data Table on Molecular diagnostics – Market size and forecast 2021-2026 ($ billion)
o Exhibit 34: Chart on Molecular diagnostics – Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Molecular diagnostics – Year-over-year growth 2021-2026 (%)
o 5.5 Clinical chemistry – Market size and forecast 2021-2026
o Exhibit 36: Chart on Clinical chemistry – Market size and forecast 2021-2026 ($ billion)
o Exhibit 37: Data Table on Clinical chemistry – Market size and forecast 2021-2026 ($ billion)
o Exhibit 38: Chart on Clinical chemistry – Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Clinical chemistry – Year-over-year growth 2021-2026 (%)
o 5.6 Hematology – Market size and forecast 2021-2026
o Exhibit 40: Chart on Hematology – Market size and forecast 2021-2026 ($ billion)
o Exhibit 41: Data Table on Hematology – Market size and forecast 2021-2026 ($ billion)
o Exhibit 42: Chart on Hematology – Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on Hematology – Year-over-year growth 2021-2026 (%)
o 5.7 Others – Market size and forecast 2021-2026
o Exhibit 44: Chart on Others – Market size and forecast 2021-2026 ($ billion)
o Exhibit 45: Data Table on Others – Market size and forecast 2021-2026 ($ billion)
o Exhibit 46: Chart on Others – Year-over-year growth 2021-2026 (%)
o Exhibit 47: Data Table on Others – Year-over-year growth 2021-2026 (%)
o 5.8 Market opportunity by Technology
o Exhibit 48: Market opportunity by Technology ($ billion)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 49: Analysis of price sensitivity、lifecycle、customer purchase basket、adoption rates、and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 50: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 52: Chart on Geographic comparison
o Exhibit 53: Data Table on Geographic comparison
o 7.3 North America – Market size and forecast 2021-2026
o Exhibit 54: Chart on North America – Market size and forecast 2021-2026 ($ billion)
o Exhibit 55: Data Table on North America – Market size and forecast 2021-2026 ($ billion)
o Exhibit 56: Chart on North America – Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on North America – Year-over-year growth 2021-2026 (%)
o 7.4 Europe – Market size and forecast 2021-2026
o Exhibit 58: Chart on Europe – Market size and forecast 2021-2026 ($ billion)
o Exhibit 59: Data Table on Europe – Market size and forecast 2021-2026 ($ billion)
o Exhibit 60: Chart on Europe – Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Europe – Year-over-year growth 2021-2026 (%)
o 7.5 Asia – Market size and forecast 2021-2026
o Exhibit 62: Chart on Asia – Market size and forecast 2021-2026 ($ billion)
o Exhibit 63: Data Table on Asia – Market size and forecast 2021-2026 ($ billion)
o Exhibit 64: Chart on Asia – Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Asia – Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) – Market size and forecast 2021-2026
o Exhibit 66: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ billion)
o Exhibit 67: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ billion)
o Exhibit 68: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o 7.7 US – Market size and forecast 2021-2026
o Exhibit 70: Chart on US – Market size and forecast 2021-2026 ($ billion)
o Exhibit 71: Data Table on US – Market size and forecast 2021-2026 ($ billion)
o Exhibit 72: Chart on US – Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on US – Year-over-year growth 2021-2026 (%)
o 7.8 China – Market size and forecast 2021-2026
o Exhibit 74: Chart on China – Market size and forecast 2021-2026 ($ billion)
o Exhibit 75: Data Table on China – Market size and forecast 2021-2026 ($ billion)
o Exhibit 76: Chart on China – Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on China – Year-over-year growth 2021-2026 (%)
o 7.9 Japan – Market size and forecast 2021-2026
o Exhibit 78: Chart on Japan – Market size and forecast 2021-2026 ($ billion)
o Exhibit 79: Data Table on Japan – Market size and forecast 2021-2026 ($ billion)
o Exhibit 80: Chart on Japan – Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Japan – Year-over-year growth 2021-2026 (%)
o 7.10 Germany – Market size and forecast 2021-2026
o Exhibit 82: Chart on Germany – Market size and forecast 2021-2026 ($ billion)
o Exhibit 83: Data Table on Germany – Market size and forecast 2021-2026 ($ billion)
o Exhibit 84: Chart on Germany – Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on Germany – Year-over-year growth 2021-2026 (%)
o 7.11 Canada – Market size and forecast 2021-2026
o Exhibit 86: Chart on Canada – Market size and forecast 2021-2026 ($ billion)
o Exhibit 87: Data Table on Canada – Market size and forecast 2021-2026 ($ billion)
o Exhibit 88: Chart on Canada – Year-over-year growth 2021-2026 (%)
o Exhibit 89: Data Table on Canada – Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 90: Market opportunity By Geographical Landscape ($ billion)
• 8 Drivers、Challenges、and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 91: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 93: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 94: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 95: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 96: Matrix on vendor position and classification
o 10.3 Abbott Laboratories
o Exhibit 97: Abbott Laboratories – Overview
o Exhibit 98: Abbott Laboratories – Business segments
o Exhibit 99: Abbott Laboratories – Key news
o Exhibit 100: Abbott Laboratories – Key offerings
o Exhibit 101: Abbott Laboratories – Segment focus
o 10.4 Danaher Corp.
o Exhibit 102: Danaher Corp. – Overview
o Exhibit 103: Danaher Corp. – Business segments
o Exhibit 104: Danaher Corp. – Key news
o Exhibit 105: Danaher Corp. – Key offerings
o Exhibit 106: Danaher Corp. – Segment focus
o 10.5 DiaSorin SpA
o Exhibit 107: DiaSorin SpA – Overview
o Exhibit 108: DiaSorin SpA – Business segments
o Exhibit 109: DiaSorin SpA – Key news
o Exhibit 110: DiaSorin SpA – Key offerings
o Exhibit 111: DiaSorin SpA – Segment focus
o 10.6 F. Hoffmann La Roche Ltd.
o Exhibit 112: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 113: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 114: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 115: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 116: F. Hoffmann La Roche Ltd. – Segment focus
o 10.7 Illumina Inc.
o Exhibit 117: Illumina Inc. – Overview
o Exhibit 118: Illumina Inc. – Business segments
o Exhibit 119: Illumina Inc. – Key news
o Exhibit 120: Illumina Inc. – Key offerings
o Exhibit 121: Illumina Inc. – Segment focus
o 10.8 Ortho Clinical Diagnostics plc
o Exhibit 122: Ortho Clinical Diagnostics plc – Overview
o Exhibit 123: Ortho Clinical Diagnostics plc – Business segments
o Exhibit 124: Ortho Clinical Diagnostics plc – Key offerings
o Exhibit 125: Ortho Clinical Diagnostics plc – Segment focus
o 10.9 Quest Diagnostics Inc.
o Exhibit 126: Quest Diagnostics Inc. – Overview
o Exhibit 127: Quest Diagnostics Inc. – Business segments
o Exhibit 128: Quest Diagnostics Inc. – Key offerings
o Exhibit 129: Quest Diagnostics Inc. – Segment focus
o 10.10 Siemens AG
o Exhibit 130: Siemens AG – Overview
o Exhibit 131: Siemens AG – Business segments
o Exhibit 132: Siemens AG – Key news
o Exhibit 133: Siemens AG – Key offerings
o Exhibit 134: Siemens AG – Segment focus
o 10.11 Sysmex Corp
o Exhibit 135: Sysmex Corp – Overview
o Exhibit 136: Sysmex Corp – Business segments
o Exhibit 137: Sysmex Corp – Key offerings
o Exhibit 138: Sysmex Corp – Segment focus
o 10.12 Thermo Fisher Scientific Inc.
o Exhibit 139: Thermo Fisher Scientific Inc. – Overview
o Exhibit 140: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 141: Thermo Fisher Scientific Inc. – Key news
o Exhibit 142: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 143: Thermo Fisher Scientific Inc. – Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 144: Inclusions checklist
o Exhibit 145: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 146: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 147: Research methodology
o Exhibit 148: Validation techniques employed for market sizing
o Exhibit 149: Information sources
o 11.5 List of abbreviations
o Exhibit 150: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Technology
Exhibits6: Executive Summary – Chart on Incremental Growth
Exhibits7: Executive Summary – Data Table on Incremental Growth
Exhibits8: Executive Summary – Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global – Market size and forecast 2021-2026 ($ billion)
Exhibits14: Data Table on Global – Market size and forecast 2021-2026 ($ billion)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis – Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants – Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes – Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry – Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition – Five forces 2021 and 2026
Exhibits24: Chart on Technology – Market share 2021-2026 (%)
Exhibits25: Data Table on Technology – Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Technology
Exhibits27: Data Table on Comparison by Technology
Exhibits28: Chart on Immunoassay – Market size and forecast 2021-2026 ($ billion)
Exhibits29: Data Table on Immunoassay – Market size and forecast 2021-2026 ($ billion)
Exhibits30: Chart on Immunoassay – Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Immunoassay – Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Molecular diagnostics – Market size and forecast 2021-2026 ($ billion)
Exhibits33: Data Table on Molecular diagnostics – Market size and forecast 2021-2026 ($ billion)
Exhibits34: Chart on Molecular diagnostics – Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Molecular diagnostics – Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Clinical chemistry – Market size and forecast 2021-2026 ($ billion)
Exhibits37: Data Table on Clinical chemistry – Market size and forecast 2021-2026 ($ billion)
Exhibits38: Chart on Clinical chemistry – Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Clinical chemistry – Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Hematology – Market size and forecast 2021-2026 ($ billion)
Exhibits41: Data Table on Hematology – Market size and forecast 2021-2026 ($ billion)
Exhibits42: Chart on Hematology – Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Hematology – Year-over-year growth 2021-2026 (%)
Exhibits44: Chart on Others – Market size and forecast 2021-2026 ($ billion)
Exhibits45: Data Table on Others – Market size and forecast 2021-2026 ($ billion)
Exhibits46: Chart on Others – Year-over-year growth 2021-2026 (%)
Exhibits47: Data Table on Others – Year-over-year growth 2021-2026 (%)
Exhibits48: Market opportunity by Technology ($ billion)
Exhibits49: Analysis of price sensitivity、lifecycle、customer purchase basket、adoption rates、and purchase criteria
Exhibits50: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits52: Chart on Geographic comparison
Exhibits53: Data Table on Geographic comparison
Exhibits54: Chart on North America – Market size and forecast 2021-2026 ($ billion)
Exhibits55: Data Table on North America – Market size and forecast 2021-2026 ($ billion)
Exhibits56: Chart on North America – Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on North America – Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Europe – Market size and forecast 2021-2026 ($ billion)
Exhibits59: Data Table on Europe – Market size and forecast 2021-2026 ($ billion)
Exhibits60: Chart on Europe – Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Europe – Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Asia – Market size and forecast 2021-2026 ($ billion)
Exhibits63: Data Table on Asia – Market size and forecast 2021-2026 ($ billion)
Exhibits64: Chart on Asia – Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Asia – Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ billion)
Exhibits67: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ billion)
Exhibits68: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on US – Market size and forecast 2021-2026 ($ billion)
Exhibits71: Data Table on US – Market size and forecast 2021-2026 ($ billion)
Exhibits72: Chart on US – Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on US – Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on China – Market size and forecast 2021-2026 ($ billion)
Exhibits75: Data Table on China – Market size and forecast 2021-2026 ($ billion)
Exhibits76: Chart on China – Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on China – Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Japan – Market size and forecast 2021-2026 ($ billion)
Exhibits79: Data Table on Japan – Market size and forecast 2021-2026 ($ billion)
Exhibits80: Chart on Japan – Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Japan – Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on Germany – Market size and forecast 2021-2026 ($ billion)
Exhibits83: Data Table on Germany – Market size and forecast 2021-2026 ($ billion)
Exhibits84: Chart on Germany – Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on Germany – Year-over-year growth 2021-2026 (%)
Exhibits86: Chart on Canada – Market size and forecast 2021-2026 ($ billion)
Exhibits87: Data Table on Canada – Market size and forecast 2021-2026 ($ billion)
Exhibits88: Chart on Canada – Year-over-year growth 2021-2026 (%)
Exhibits89: Data Table on Canada – Year-over-year growth 2021-2026 (%)
Exhibits90: Market opportunity By Geographical Landscape ($ billion)
Exhibits91: Impact of drivers and challenges in 2021 and 2026
Exhibits92: Overview on Criticality of inputs and Factors of differentiation
Exhibits93: Overview on factors of disruption
Exhibits94: Impact of key risks on business
Exhibits95: Vendors covered
Exhibits96: Matrix on vendor position and classification
Exhibits97: Abbott Laboratories – Overview
Exhibits98: Abbott Laboratories – Business segments
Exhibits99: Abbott Laboratories – Key news
Exhibits100: Abbott Laboratories – Key offerings
Exhibits101: Abbott Laboratories – Segment focus
Exhibits102: Danaher Corp. – Overview
Exhibits103: Danaher Corp. – Business segments
Exhibits104: Danaher Corp. – Key news
Exhibits105: Danaher Corp. – Key offerings
Exhibits106: Danaher Corp. – Segment focus
Exhibits107: DiaSorin SpA – Overview
Exhibits108: DiaSorin SpA – Business segments
Exhibits109: DiaSorin SpA – Key news
Exhibits110: DiaSorin SpA – Key offerings
Exhibits111: DiaSorin SpA – Segment focus
Exhibits112: F. Hoffmann La Roche Ltd. – Overview
Exhibits113: F. Hoffmann La Roche Ltd. – Business segments
Exhibits114: F. Hoffmann La Roche Ltd. – Key news
Exhibits115: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits116: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits117: Illumina Inc. – Overview
Exhibits118: Illumina Inc. – Business segments
Exhibits119: Illumina Inc. – Key news
Exhibits120: Illumina Inc. – Key offerings
Exhibits121: Illumina Inc. – Segment focus
Exhibits122: Ortho Clinical Diagnostics plc – Overview
Exhibits123: Ortho Clinical Diagnostics plc – Business segments
Exhibits124: Ortho Clinical Diagnostics plc – Key offerings
Exhibits125: Ortho Clinical Diagnostics plc – Segment focus
Exhibits126: Quest Diagnostics Inc. – Overview
Exhibits127: Quest Diagnostics Inc. – Business segments
Exhibits128: Quest Diagnostics Inc. – Key offerings
Exhibits129: Quest Diagnostics Inc. – Segment focus
Exhibits130: Siemens AG – Overview
Exhibits131: Siemens AG – Business segments
Exhibits132: Siemens AG – Key news
Exhibits133: Siemens AG – Key offerings
Exhibits134: Siemens AG – Segment focus
Exhibits135: Sysmex Corp – Overview
Exhibits136: Sysmex Corp – Business segments
Exhibits137: Sysmex Corp – Key offerings
Exhibits138: Sysmex Corp – Segment focus
Exhibits139: Thermo Fisher Scientific Inc. – Overview
Exhibits140: Thermo Fisher Scientific Inc. – Business segments
Exhibits141: Thermo Fisher Scientific Inc. – Key news
Exhibits142: Thermo Fisher Scientific Inc. – Key offerings
Exhibits143: Thermo Fisher Scientific Inc. – Segment focus
Exhibits144: Inclusions checklist
Exhibits145: Exclusions checklist
Exhibits146: Currency conversion rates for US$
Exhibits147: Research methodology
Exhibits148: Validation techniques employed for market sizing
Exhibits149: Information sources
Exhibits150: List of abbreviations



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 体外診断用医薬品の世界市場2022年-2026年(Global In-vitro Diagnostics Market 2022-2026)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆